This content is machine translated Varicella zoster virus (VZV) Shingles risk is often underestimated The “Shingles Misconception Survey” is an online survey conducted between August 16-18, 2023 among 3,500 adults aged 50 and over. The evaluations show that 86% of respondents underestimate the risk…
View Post 4 min This content is machine translated Shingles Herpes zoster vaccine provides long-lasting protection for adults 50 and older Interim analysis of the follow-up phase of two phase III trials show that recombinant adjuvanted zoster vaccine protects against herpes zoster for at least 10 years overall after initial vaccination.…
View Post 10 min This content is machine translated Herpes zoster Efficient vaccination prevention Herpes zoster is a burdensome and potentially dangerous disease, but now efficiently and readily preventable through vaccination. The recombinant adjuvanted zoster vaccine provides effective prophylaxis for patients. Preventive health care… CME-Test
View Post 6 min This content is machine translated Now cash-registered and available in Switzerland Highly effective herpes zoster vaccine approved The Federal Office of Public Health (FOPH) and the Swiss Federal Commission for Immunization Questions (EKIF) recommend vaccination against herpes zoster with the new recombinant inactivated vaccine consisting of the…
View Post 7 min This content is machine translated Herpes zoster in the family practice The “uninvited visitor” returns One in three people contract “shingles” once in their lifetime. The disease is very painful and can cause high suffering. The complications are also feared above all.
